<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Matthews Emerging Markets Discovery Active Etf — News on 6ix</title>
    <link>https://6ix.com/company/matthews-emerging-markets-discovery-active-etf</link>
    <description>Latest news and press releases for Matthews Emerging Markets Discovery Active Etf on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Thu, 02 Apr 2026 04:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/matthews-emerging-markets-discovery-active-etf" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683597ae78dffbe2df1051a3.webp</url>
      <title>Matthews Emerging Markets Discovery Active Etf</title>
      <link>https://6ix.com/company/matthews-emerging-markets-discovery-active-etf</link>
    </image>
    <item>
      <title>Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies</title>
      <link>https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/biodexa-announces-partnership-with-syngene-to-manufacture-mtx240-gmp-clinical-trial-supplies-12</link>
      <guid isPermaLink="true">https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/biodexa-announces-partnership-with-syngene-to-manufacture-mtx240-gmp-clinical-trial-supplies-12</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>April 2, 2026 Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies Biodexa Pharmaceuticals PLC (Nasdaq: BDRX)</description>
    </item>
    <item>
      <title>Cycurion Goes on Offense: Initiates Legal Action and Seeks Millions in Damages Against ACCESS Newswire and Those Responsible for Disseminating the Unauthorized and Fraudulent Release</title>
      <link>https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/cycurion-goes-on-offense-initiates-legal-action-and-seeks-millions-in-damages-against-access-newswire-and-those-responsible-for-disseminating-the-unauthorized-and-fraudulent-release-6</link>
      <guid isPermaLink="true">https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/cycurion-goes-on-offense-initiates-legal-action-and-seeks-millions-in-damages-against-access-newswire-and-those-responsible-for-disseminating-the-unauthorized-and-fraudulent-release-6</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>MCLEAN, Va., April 02, 2026 (GLOBE NEWSWIRE) -- Cycurion, Inc. (Nasdaq: CYCU) (“Cycurion” or the “Company”), a trusted leader in IT cybersecurity and</description>
    </item>
    <item>
      <title>LandBridge Announces Agreement with PowerBridge for the Development of a 2 GW Powered Data Center Campus</title>
      <link>https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/landbridge-announces-agreement-with-powerbridge-for-the-development-of-a-2-gw-powered-data-center-campus-1</link>
      <guid isPermaLink="true">https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/landbridge-announces-agreement-with-powerbridge-for-the-development-of-a-2-gw-powered-data-center-campus-1</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>Agreement provides option to lease acreage for the development of a 2 GW powered data center campus in West Texas on LandBridge acreage in close proximity to</description>
    </item>
    <item>
      <title>Ultragenyx Announces U.S. FDA Acceptance of BLA Resubmission for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)</title>
      <link>https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/ultragenyx-announces-us-fda-acceptance-of-bla-resubmission-for-ux111-aav-gene-therapy-to-treat-sanfilippo-syndrome-type-a-mps-iiia-14</link>
      <guid isPermaLink="true">https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/ultragenyx-announces-us-fda-acceptance-of-bla-resubmission-for-ux111-aav-gene-therapy-to-treat-sanfilippo-syndrome-type-a-mps-iiia-14</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>If approved, UX111 will be the first approved therapy for the treatment of Sanfilippo syndrome Type A, a rare disease affecting young children that leads to</description>
    </item>
    <item>
      <title>Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market</title>
      <link>https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/intelligent-bio-solutions-completes-clinical-cut-off-study-advances-fda-510k-clinical-program-targeting-multi-billion-dollar-us-drug-screening-market-12</link>
      <guid isPermaLink="true">https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/intelligent-bio-solutions-completes-clinical-cut-off-study-advances-fda-510k-clinical-program-targeting-multi-billion-dollar-us-drug-screening-market-12</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>Study results finalized on schedule support FDA clearance and planned U.S. commercial launch Company advances second phase of clinical program for 510(k)</description>
    </item>
    <item>
      <title>SurgePays Launches Stored Value and Loyalty Platform Across Retail Network</title>
      <link>https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/surgepays-launches-stored-value-and-loyalty-platform-across-retail-network-6</link>
      <guid isPermaLink="true">https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/surgepays-launches-stored-value-and-loyalty-platform-across-retail-network-6</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>New Platform Capabilities Designed to Increase Revenue Per Store and Further Integrate SurgePays into Core Merchant Operations BARTLETT, Tenn., April 02, 2026</description>
    </item>
    <item>
      <title>Dalrada Technology Group, Inc. Announces Agreement Supporting Ultra-High Temperature Industrial Heat Pump Development</title>
      <link>https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/dalrada-technology-group-inc-announces-agreement-supporting-ultra-high-temperature-industrial-heat-pump-development-19</link>
      <guid isPermaLink="true">https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/dalrada-technology-group-inc-announces-agreement-supporting-ultra-high-temperature-industrial-heat-pump-development-19</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>ESCONDIDO, CA / ACCESS Newswire / April 2, 2026 / Dalrada Technology Group, Inc. (the &quot;Company&quot; or &quot;Dalrada&quot;) (OTCID:DHTI), a leader in advanced climate</description>
    </item>
    <item>
      <title>Rivian Releases Q1 2026 Production and Delivery Figures and Sets Date for First Quarter 2026 Financial Results</title>
      <link>https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/rivian-releases-q1-2026-production-and-delivery-figures-and-sets-date-for-first-quarter-2026-financial-results-2</link>
      <guid isPermaLink="true">https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/rivian-releases-q1-2026-production-and-delivery-figures-and-sets-date-for-first-quarter-2026-financial-results-2</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>IRVINE, Calif.--(BUSINESS WIRE)-- Rivian Automotive, Inc. (NASDAQ: RIVN) today announced production and delivery totals for the quarter ending March 31,</description>
    </item>
    <item>
      <title>Quantum BioPharma Wins Significant Court Challenge in USD $700,000,000 Claim as Defendants Joint Motion to Dismiss Lawsuit Alleging Market Manipulation by CIBC World Markets and RBC Dominion Securities is Denied</title>
      <link>https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/quantum-biopharma-wins-significant-court-challenge-in-usd-dollar700000000-claim-as-defendants-joint-motion-to-dismiss-lawsuit-alleging-market-manipulation-by-cibc-world-markets-and-rbc-dominion-securities-is-denied-6</link>
      <guid isPermaLink="true">https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/quantum-biopharma-wins-significant-court-challenge-in-usd-dollar700000000-claim-as-defendants-joint-motion-to-dismiss-lawsuit-alleging-market-manipulation-by-cibc-world-markets-and-rbc-dominion-securities-is-denied-6</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>TORONTO, April 02, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a</description>
    </item>
    <item>
      <title>Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time</title>
      <link>https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/dexcom-schedules-first-quarter-2026-earnings-release-and-conference-call-for-april-30-2026-at-430-pm-eastern-time-2</link>
      <guid isPermaLink="true">https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/dexcom-schedules-first-quarter-2026-earnings-release-and-conference-call-for-april-30-2026-at-430-pm-eastern-time-2</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2026 financial results after market close</description>
    </item>
    <item>
      <title>InterDigital signs license agreement with Buffalo Americas; adds new DTV agreements</title>
      <link>https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/interdigital-signs-license-agreement-with-buffalo-americas-adds-new-dtv-agreements-10</link>
      <guid isPermaLink="true">https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/interdigital-signs-license-agreement-with-buffalo-americas-adds-new-dtv-agreements-10</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>WILMINGTON, Del., April 02, 2026 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a wireless, video, and AI technology research and development company,</description>
    </item>
    <item>
      <title>ZenaTech Initiates New Operations in Ukraine to Accelerate Production of Counter-UAS Interceptor Systems</title>
      <link>https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/zenatech-initiates-new-operations-in-ukraine-to-accelerate-production-of-counter-uas-interceptor-systems-13</link>
      <guid isPermaLink="true">https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/zenatech-initiates-new-operations-in-ukraine-to-accelerate-production-of-counter-uas-interceptor-systems-13</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>Ukraine operations will be structured for full regulatory compliance to support U.S. defense and Gulf nation adoption VANCOUVER, British Columbia, April 02,</description>
    </item>
    <item>
      <title>Carpenter Technology Announces Conference Call and Webcast</title>
      <link>https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/carpenter-technology-announces-conference-call-and-webcast-9</link>
      <guid isPermaLink="true">https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/carpenter-technology-announces-conference-call-and-webcast-9</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>PHILADELPHIA, April 02, 2026 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) plans to host a conference call and webcast on Wednesday, April</description>
    </item>
    <item>
      <title>CSW Industrials Increases Quarterly Dividend by 11% to $0.30 Per Share and Repurchases $35M in Shares During the Fiscal Fourth Quarter of 2026</title>
      <link>https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/csw-industrials-increases-quarterly-dividend-by-11percent-to-dollar030-per-share-and-repurchases-dollar35m-in-shares-during-the-fiscal-fourth-quarter-of-2026-16</link>
      <guid isPermaLink="true">https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/csw-industrials-increases-quarterly-dividend-by-11percent-to-dollar030-per-share-and-repurchases-dollar35m-in-shares-during-the-fiscal-fourth-quarter-of-2026-16</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>DALLAS, April 02, 2026 (GLOBE NEWSWIRE) -- CSW Industrials, Inc. (NYSE: CSW) announced today that its Board of Directors has declared a regular quarterly cash</description>
    </item>
    <item>
      <title>Forward Air Named to Newsweek’s List of Most Trustworthy Companies in America 2026</title>
      <link>https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/forward-air-named-to-newsweeks-list-of-most-trustworthy-companies-in-america-2026-2</link>
      <guid isPermaLink="true">https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/forward-air-named-to-newsweeks-list-of-most-trustworthy-companies-in-america-2026-2</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>DALLAS--(BUSINESS WIRE)-- Forward Air Corporation (NASDAQ: FWRD) (“Forward” or the “Company”) today announced it has been named to Newsweek’s list of the</description>
    </item>
    <item>
      <title>Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York</title>
      <link>https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/abeona-therapeuticsr-announces-new-qualified-treatment-center-for-zevaskynr-in-new-york-11</link>
      <guid isPermaLink="true">https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/abeona-therapeuticsr-announces-new-qualified-treatment-center-for-zevaskynr-in-new-york-11</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>CLEVELAND, April 02, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced activation of NewYork-Presbyterian/Columbia University</description>
    </item>
    <item>
      <title>QT Imaging CEO Discusses the Importance of Early Breast Cancer Detection at the Shiftmakers’ Panel and Gala</title>
      <link>https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/qt-imaging-ceo-discusses-the-importance-of-early-breast-cancer-detection-at-the-shiftmakers-panel-and-gala-2</link>
      <guid isPermaLink="true">https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/qt-imaging-ceo-discusses-the-importance-of-early-breast-cancer-detection-at-the-shiftmakers-panel-and-gala-2</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>NOVATO, Calif.--(BUSINESS WIRE)-- QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming</description>
    </item>
    <item>
      <title>LiveRamp Unlocks Identity-Driven Marketing with Unity to Power Better Returns in Gaming</title>
      <link>https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/liveramp-unlocks-identity-driven-marketing-with-unity-to-power-better-returns-in-gaming</link>
      <guid isPermaLink="true">https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/liveramp-unlocks-identity-driven-marketing-with-unity-to-power-better-returns-in-gaming</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>SAN FRANCISCO--(BUSINESS WIRE)-- LiveRamp (NYSE: RAMP), the leader in data collaboration, today announced an expanded partnership with Unity (NYSE: U), the</description>
    </item>
    <item>
      <title>Plato Gold Corp. Announces Sale of Timmins-Area Properties to Mayfair Gold Corp.</title>
      <link>https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/plato-gold-corp-announces-sale-of-timmins-area-properties-to-mayfair-gold-corp-6</link>
      <guid isPermaLink="true">https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/plato-gold-corp-announces-sale-of-timmins-area-properties-to-mayfair-gold-corp-6</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>TORONTO, Ontario, April 02, 2026 (GLOBE NEWSWIRE) -- Plato Gold Corp. (TSX-V: PGC) (OTCQB: NIOVF) (Frankfurt: 4Y7 or WKN: A0M2QX) (“Plato” or the “Company”)</description>
    </item>
    <item>
      <title>Small Business Sales Grew Steadily in March as Higher Ticket Sizes Offset Softer Foot Traffic, Fiserv Data Shows</title>
      <link>https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/small-business-sales-grew-steadily-in-march-as-higher-ticket-sizes-offset-softer-foot-traffic-fiserv-data-shows-2</link>
      <guid isPermaLink="true">https://6ix.com/company/matthews-emerging-markets-discovery-active-etf/news/small-business-sales-grew-steadily-in-march-as-higher-ticket-sizes-offset-softer-foot-traffic-fiserv-data-shows-2</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>Fiserv Small Business Index rises to 144; year-over-year sales grew +1.3% MILWAUKEE, April 02, 2026 (GLOBE NEWSWIRE) -- Fiserv, Inc. (NASDAQ: FISV), a leading</description>
    </item>
  </channel>
</rss>